AI assistant
DE LA RUE PLC — Director's Dealing 2018
Jun 14, 2018
4600_dirs_2018-06-14_152a0f97-8a77-49c3-af0b-b73ee87e234e.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4479R
De La Rue PLC
14 June 2018
De La Rue plc
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
De La Rue plc (the "Company") announces the following changes in the interests of Directors and Persons Discharging Managerial Responsibilities (PDMRs) in ordinary shares of 44 152/175p ("Shares") in the capital of the Company.
De La Rue Sharesave Scheme ("Sharesave Scheme")
On 13 June 2018, the Directors and PDMRs, listed below, completed the exercise of options over Shares in the capital of the Company, granted under the Sharesave Scheme on 6 January 2015, with an Option Price of £4.38 per share.
| Name | Director/ PDMR | Number of Options Exercised |
| Martin Sutherland | Director/PDMR | 2,876 |
| Joanne Easton | PDMR | 2,876 |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Ed Peppiatt, Company Secretary
Contact Number: 01256 605343
14 June 2018
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Martin Sutherland
2
Reason for the notification
a)
Position/status
Chief Executive Officer (PDMR)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
De La Rue plc
b)
LEI
213800DH741LZWIJXP78
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 44 152/175p
GB00B3DGH821
b)
Nature of the transaction
Acquisition of shares following the exercise of 2,876 options granted under The De La Rue Sharesave Scheme (Option Price £4.38).
Following this transaction Mr Sutherland's beneficial holding is 70,409 ordinary shares.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £4.38 | 2,876 |
d)
Aggregated information
- Aggregated volume
- Price
- Aggregated total
2,876
£4.38
£12,596.88
e)
Date of the transaction
2018-06-13
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Joanne Easton
2
Reason for the notification
a)
Position/status
Group Director of HR (PDMR)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
De La Rue plc
b)
LEI
213800DH741LZWIJXP78
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 44 152/175p
GB00B3DGH821
b)
Nature of the transaction
Acquisition of shares following the exercise of 2,876 options granted under The De La Rue Sharesave Scheme (Option Price £4.38).
Following this transaction Ms Easton's beneficial holding is 16,961 ordinary shares.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £4.38 | 2,876 |
d)
Aggregated information
- Aggregated volume
- Price
- Aggregated total
2,876
£4.38
£12,596.88
e)
Date of the transaction
2018-06-13
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEADKLFADPEFF